Xcenda’s FormularyDecisions Launches Resource Hub for Biosimilars

Shots:

• FormularyDecisions’ new feature will provide registered users with centralized access to pertinent product and drug pipeline information, regulatory guidance and state-specific substitution laws
• The biosimilar hub will provide users an interactive chart of the US biosimilar market landscape, curated biosimilar resources and dynamic repository of state substitution laws for biosimilar products
• With the hub, the company is providing the payers with information at all stages of the product lifecycle in an easily accessible format, ultimately helping to enhance the formulary decision-making process

Click here to­ read full press release/ article | Ref: Businesswire | Image: Twitter